Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.55p -2.99% 17.85p 17.90p 18.30p 18.50p 17.50p 18.50p 652,187 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 67.00

Circassia Pharmaceuticals Plc Result of AGM

07/06/2019 4:18pm

UK Regulatory (RNS & others)


Circassia Pharmaceuticals (LSE:CIR)
Historical Stock Chart

2 Months : From May 2019 to Jul 2019

Click Here for more Circassia Pharmaceuticals Charts.

TIDMCIR

RNS Number : 5813B

Circassia Pharmaceuticals Plc

07 June 2019

7 June 2019

Circassia Pharmaceuticals plc

Result of Annual General Meeting 2019 and Re Directorate

Circassia Pharmaceuticals plc ("Circassia") announces that at its Annual General Meeting held today all resolutions set out in the notice of Annual General Meeting dated 1 May 2019 were passed. A poll was conducted on each resolution proposed at the Meeting and the number of votes cast for and against each of the resolutions, and the number of votes withheld, were as follows:

 
      Resolution                             For           %        Against   %      Withheld* 
      To receive the Annual report 
 1     and accounts                          322,919,875   100.00   13        0.00   7,000 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To approve the Directors' 
 2     Annual report on remuneration         322,890,903   99.99    33,885    0.01   2,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To approve the Directors' 
 3     Remuneration policy                   321,934,551   99.69    990,237   0.31   2,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To approve amendments to 
       the rules of the Circassia 
       Pharmaceuticals plc Performance 
 4     Share Plan                            321,937,169   99.99    29,184    0.01   960,535 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 5    To re-elect Francesco Granata          322,893,492   99.99    26,296    0.01   7,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 6    To re-elect Steven Harris              322,893,492   99.99    26,296    0.01   7,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 7    To re-elect Julien Cotta               321,944,717   99.99    23,636    0.01   958,535 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 8    To re-elect Rod Hafner                 322,893,459   99.99    26,329    0.01   7,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 9    To re-elect Jo le Couilliard           322,896,152   99.99    23,636    0.01   7,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 10   To re-elect Sharon Curran              322,896,152   99.99    18,636    0.01   12,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To re-appoint PricewaterhouseCoopers 
 11    LLP as Auditors                       321,962,457   99.70    956,141   0.30   8,290 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To give authority to determine 
 12    the Auditors' remuneration            322,896,152   99.99    16,636    0.01   14,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To give authority to allot 
 13    shares                                322,890,902   99.99    23,886    0.01   12,100 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To give authority to disapply 
 14    pre-emption rights**                  322,889,262   99.99    22,288    0.01   15,788 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
      To give authority to disapply 
       pre-emption rights in respect 
       of an additional 5% of the 
 15    Company's issued share capital**      321,939,017   99.70    973,723   0.30   14,598 
     -------------------------------------  ------------  -------  --------  -----  ---------- 
 

* A vote withheld is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

** Special resolution.

As previously announced Russ Cummings did not seek re-election at the Annual General Meeting and accordingly has today stepped down as a Director.

For enquiries, contact:

 
 Julien Cotta, Company Secretary                  Tel: +44 (0)1865 405560 
 Peel Hunt (Nominated Adviser and Joint Broker)   Tel: +44 (0) 20 7418 
  James Steel / Dr Christopher Golden              8900 
 Numis Securities (Joint Broker)                  Tel: +44 (0) 20 7260 
  James Black / Freddie Barnfield                  1000 
 FTI Consulting                                   Tel: +44 (0) 20 3727 
  Simon Conway / Ciara Martin                      1000 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGLLFLERDIDIIA

(END) Dow Jones Newswires

June 07, 2019 11:18 ET (15:18 GMT)

1 Year Circassia Pharmaceuticals Chart

1 Year Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190716 23:01:40